Blood pressure on arising, morning blood pressure surge and blood pressure variability in white coat hypertensives and in matched normotensives and sustained hypertensives;Avaliação comparativa da pressão ao levantar, da subida matinal da pressão arterial e da variabilidade diurna da pressão arterial em normotensos, hipertensos da bata branca e em hipertensos

Revista Portuguesa de Cardiologia

Volumn 25, Issue 7-8, 2006, Pages 693-704

  Polónia, Jorge ^a   Carvalho, Nuno ^b   Barbosa, Loide ^b   Silva, José A ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b NONE

Author keywords

Blood pressure morning surge; Blood pressure on arising; Blood pressure variability; Normotension; Sustained hypertension; White coat hypertension

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; SEX DIFFERENCE; SEX RATIO; SYSTOLIC BLOOD PRESSURE; TUNICA ALBUGINEA;

ADULT; AGED; BLOOD PRESSURE; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 33749600930     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21(6):1011-53.
2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.
3. Pickering TG. Utility of 24 h ambulatory blood pressure monitoring in clinical practice. Can J Cardiol 1995;11 Suppl H:43H-48H.
4. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood Pressure Monitoring. Task force V: White-coat hypertension. Blood Press Monit 1999;4(6):333-41.
5. Mancia G, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Circulation 1997;95(6):1464-1470.
6. Staessen JA, Beilin L, Parati G, Waeber B, White W. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Blood Press Monit 1999;4(6):319-31.
7. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white coat effect. Hypertension 1997;29(6):1218-24.
8. Marques da Silva P. Efeito da bata branca. Uma nova reavaliaç ão ou uma variação de um tema que persiste sem resposta? Rev Port Cardiol 2002;21(5):533-38.
9. Mancia G, Parati G, Pomidossi G, et al. Doctor-elicited blood pressure rises at the time of sphygmomanometric blood pressure assessment persist over repeated visits. J Hypertens Suppl 1985;3 Suppl 3:S421-3.
10. Hoegholm A, Kristensen KS, Bang LE, Nielsen JW. White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry. J Hum Hypertens 1998;12(7):433-9.
11. Fagard R, Staessen J, Thijs L. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens 1997;15(12):1493-1502.
12. Polonia JJ, Gama GM, Silva JA, Amaral C, Martins LR, Bertoquini SE. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives. Blood Press Monit 2005;10(2):57-64.
13. Carmona J, Amado P, Vasconcelos N, et al. "White-coat hypertension": variation of normality or of hypertension? Rev Port Cardiol 1998;17(6):505-12.
14. Pierdomenico SD, Lapenna D, Guglielmi MD, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995;26(5):801-7.
15. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995;26(3):413-9.
16. Ribeiro L, Gama G, Santos A, Asmar R, Martins L, Polonia J. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives. Blood Press Monit 2000;5(1):11-7.
17. Verdecchia P, Porcallati C. Prognostic value of ambulatory blood pressure monitoring. J Hypertens 1995;13(3):373-4.
18. Cerasola G, Cottone S, Nardi E, et al. White-coat hypertension and cardiovascular risk. J Cardiovasc Risk. 1995;2(6):545-9.
19. Muscholl MW, Hense HW, Brockel U, Doring A, Riegger GA, Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998;317(7158):565-70.
20. Mallion JM, Baguet JP, Siche JP, Tremel F, De Gaudemaris R. Clinical value of ambulatory blood pressure monitoring. J Hypertens 1999;17(5):585-95.
21. Bidlingmeyer I, et al. Isolated office hypertension: a prehypertensive state? J Hypertens 1998;12(4):327-332.
22. Saito I, Murata K, Tsujioka M, Kawabe H, Saruta T. Long-term changes in clinic blood pressure in patients with white-coat hypertension. Blood Press Monit 1998;3(2):97-100.
23. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998;98(18):1892-7.
24. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001;38(1):238-45.
25. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens. 2003;17(12):811-7.
26. White WB. Relevance of blood pressure variation in the circadian onset of cardiovascular events. J Hypertens 2003;21 Suppl 6:S9-15.
27. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987;60(10):801-6.
28. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70(1):65-8.
29. Willich SN. European survey on circadian variation of angina pectoris (ESCVA): design and preliminary results. J Cardiovasc Pharmacol 1999;34 Suppl 2:S9-13; discussion S29-31.
30. Polonia J, Amado P, Barbosa L, et al. Morning rise, morning surge and daytime variability of blood pressure and cardiovascular target organ damage. A cross-sectional study in 743 subjects. Rev Port Cardiol. 2005;24(1):65-78.
31. Dodt C, Breckling U, Derad I, Fehm HL, Born J. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997;30(1 Pt 1):71-6.
32. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316(24):1514-8.
33. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003;107(10):1401-6.
34. Kario K, Pickering TG, Hoshide S, et al. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004;17(8):668-75.
35. Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens 2004;22(6):1113-8.
36. Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000;36(5):901-6.
37. Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002;39(2 Pt 2):710-4.
38. Verdecchia P, Borgioni C, Ciucci A, et al. Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit 1996;1(1):3-11.
39. Eto M, Toba K, Akishita M. Reduced endothelial vasomotor function enhanced neointimal formation after injury in a rat model of blood pressure lability. Hypertens Res 2003;26:991-998.
40. Gosse P, Cipriano C, Bemurat L, et al. Prognostic significance of blood pressure measured on rising. J Hum Hypertens 2001;15(6):413-7.
41. Kario K, Shimada K, Pickering TG. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharmacol 2003;42 (Suppl) 1:S87-91.
42. Parati G, Di Rienzo M, Ulian L, et al. Clinical relevance of blood pressure variability. J Hypertens (Suppl) 1998;16 (3):S25-33.
43. Kario K, Shimada K. Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure. Clin Exp Hypertens 2004;26(2):177-89.